These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29441847)
1. Yang Y; Wang W; Xiong Z; Kong J; Wang L; Qiu Y; Shen F; Huang Z Pharmazie; 2016 Sep; 71(9):514-523. PubMed ID: 29441847 [TBL] [Abstract][Full Text] [Related]
2. Activation of SIRT3 attenuates triptolide-induced toxicity through closing mitochondrial permeability transition pore in cardiomyocytes. Yang Y; Wang W; Xiong Z; Kong J; Qiu Y; Shen F; Huang Z Toxicol In Vitro; 2016 Aug; 34():128-137. PubMed ID: 27064125 [TBL] [Abstract][Full Text] [Related]
3. Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane permeabilization in cardiomyocytes. Xi Y; Wang W; Wang L; Pan J; Cheng Y; Shen F; Huang Z Toxicol Appl Pharmacol; 2018 Sep; 355():269-285. PubMed ID: 30009776 [TBL] [Abstract][Full Text] [Related]
4. Triptolide-induced oxidative stress involved with Nrf2 contribute to cardiomyocyte apoptosis through mitochondrial dependent pathways. Zhou J; Xi C; Wang W; Fu X; Jinqiang L; Qiu Y; Jin J; Xu J; Huang Z Toxicol Lett; 2014 Nov; 230(3):454-66. PubMed ID: 25169008 [TBL] [Abstract][Full Text] [Related]
5. Autophagy plays an important role in triptolide-induced apoptosis in cardiomyocytes. Zhou J; Xi C; Wang W; Yang Y; Qiu Y; Huang Z Toxicol Lett; 2015 Aug; 236(3):168-83. PubMed ID: 26007683 [TBL] [Abstract][Full Text] [Related]
6. Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by p53 activation in cardiomyocytes. Xi Y; Zhang Y; Pan J; Chen S; Lu S; Shen F; Huang Z Toxicol Lett; 2020 Jan; 318():1-11. PubMed ID: 31618665 [TBL] [Abstract][Full Text] [Related]
7. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression. Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition. Wang W; Yang Y; Xiong Z; Kong J; Fu X; Shen F; Huang Z Toxicol Appl Pharmacol; 2016 Dec; 313():195-203. PubMed ID: 27751939 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasis. Zhu X; Ma E; Ge Y; Yuan M; Guo X; Peng J; Zhu W; Ren DN; Wo D Biomed Pharmacother; 2024 May; 174():116476. PubMed ID: 38520872 [TBL] [Abstract][Full Text] [Related]
10. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide. Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats. Wang SR; Chen X; Ling S; Ni RZ; Guo H; Xu JW Biomed Pharmacother; 2019 Mar; 111():1467-1477. PubMed ID: 30841462 [TBL] [Abstract][Full Text] [Related]
12. Role of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway. Li Y; Guo L; Hou Z; Gong H; Yan M; Zhang B J Ethnopharmacol; 2021 Dec; 281():114489. PubMed ID: 34363931 [TBL] [Abstract][Full Text] [Related]
13. Triptolide impairs thioredoxin system by suppressing Notch1-mediated PTEN/Akt/Txnip signaling in hepatocytes. Shen F; Xiong Z; Kong J; Wang L; Cheng Y; Jin J; Huang Z Toxicol Lett; 2019 Jan; 300():105-115. PubMed ID: 30394310 [TBL] [Abstract][Full Text] [Related]
14. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway. Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080 [TBL] [Abstract][Full Text] [Related]
15. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813 [TBL] [Abstract][Full Text] [Related]
16. Triptolide induces atrophy of myotubes by triggering IRS-1 degradation and activating the FoxO3 pathway. Wang J; Gao X; Ren D; Zhang M; Zhang P; Lu S; Huan C; Yao Y; Zheng L; Bao Z; Zhou J Toxicol In Vitro; 2020 Jun; 65():104793. PubMed ID: 32061799 [TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin protects against triptolide-induced hepatotoxicity in mice through Nrf2 activation. Cao L-; Yan M; Ma YX; Zhang BK; Fang PF; Xiang DX; Li ZH; Gong H; Deng Y; Li HD Pharmazie; 2016 Jul; 71(7):394-397. PubMed ID: 29441915 [TBL] [Abstract][Full Text] [Related]
18. Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney. Li M; Hu T; Tie C; Qu L; Zheng H; Zhang J Proteomics; 2017 Nov; 17(22):. PubMed ID: 28895652 [TBL] [Abstract][Full Text] [Related]
19. Toxicity of triptolide and the molecular mechanisms involved. Xi C; Peng S; Wu Z; Zhou Q; Zhou J Biomed Pharmacother; 2017 Jun; 90():531-541. PubMed ID: 28402922 [TBL] [Abstract][Full Text] [Related]
20. Triptolide induces oxidative damage in NRK-52E cells through facilitating Nrf2 degradation by ubiquitination via the GSK-3β/Fyn pathway. Pan J; Shen F; Tian K; Wang M; Xi Y; Li J; Huang Z Toxicol In Vitro; 2019 Aug; 58():187-194. PubMed ID: 30926361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]